myotonic dystrophy type 1
Showing 1 - 9 of 9
Cerebrospinal Fluid Biomarkers of Myotonic Dystrophy
Recruiting
- Myotonic Dystrophy Type 1
-
Boston, MassachusettsMassachusetts General Hospital
Oct 4, 2023
Myotonic Dystrophy Type 1 Trial in Boulogne-Billancourt (Virtual Reality-training in Theory of Mind, Traditional training in
Enrolling by invitation
- Myotonic Dystrophy Type 1
- Virtual Reality-training in Theory of Mind
- Traditional training in Theory of Mind
-
Boulogne-Billancourt, FranceInstitut de Psychologie
Jun 14, 2023
Myotonic Dystrophy Type 1 Trial in United States (rhIGF-I/rhIGFBP-3, )
Completed
- Myotonic Dystrophy Type 1
- rhIGF-I/rhIGFBP-3
- placebo
-
Orange, California
- +11 more
Dec 8, 2021
Myotonic Dystrophy and Facioscapulohumeral Muscular Dystrophy
Recruiting
- Myotonic Dystrophy
- +8 more
-
Rochester, New YorkUniversity of Rochester Medical Center, Department of Neurology
Jan 3, 2022
PhenoDM1 (Myotonic Dystrophy Type 1 Natural History Study)
Completed
- Myotonic Dystrophy Type 1
-
Newcastle Upon Tyne, Tyne And Wear, United Kingdom
- +1 more
Apr 12, 2021
Multicenter Observational Study of Myotonic Dystrophy Type 1
Completed
- Myotonic Dystrophy Type 1
-
Stanford, California
- +5 more
Oct 24, 2017
Myotonic Dystrophy Type 1 Trial in Worldwide (Behavioural change intervention)
Completed
- Myotonic Dystrophy Type 1
- Behavioural change intervention
-
Paris, France
- +3 more
Jul 13, 2017
Children's Health Research Institute(CHRI), Stanford Lucile
Unknown status
- Myotonic Dystrophy Type 1
-
Stanford, CaliforniaLucile Packard Childrens Hospital, Stanford
Oct 16, 2014